January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJuly 09, 2026
The nerve repair and regeneration market grows with rising nerve injuries from accidents, chronic disorders, and trauma. Companies like Progentos and Neuraptive advance treatments, with Axogen reporting growth in surgical solutions for peripheral nerve repair. Innovation drives this expanding field....
July 09, 2026
Based on market forecasts, the global cell counting market, projected at USD 12.04 billion in 2026, is expected to reach USD 24.91 billion by 2035, growing at a CAGR of 8.41% over the forecast period. The cell counting market is growing because incorporating cell counts into flow cytometry is an easy way to improve test results and potentially save...
July 09, 2026
The organ transplant immunosuppressant drugs market size is calculated at USD 6.09 bn in 2026 is to hit USD 9.23 bn by 2035. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. Duke Children’s Hospital launched a trial on new anti-rejection medications in children....
July 09, 2026
The allergy immunotherapy market size is calculated at USD 2.31 bn in 2026 is to hit USD 4.90 bn by 2035. In 2024, Europe led the allergy immunotherapy market share of 68%, with subcutaneous immunotherapy dominating treatment types. The tablets segment held the largest market share, while the drops segment is expected to grow significantly. The all...
July 09, 2026
According to market projections, the radiation therapy sector is expected to grow from USD 8.31 billion in 2065 to USD 13.72 billion by 2035. In 2024, key investments boosted cancer treatment innovation: £2.94M to RadNet Leeds for radiation research, £70M for new radiation equipment after lobbying by Radiation UK, and £1.5B for su...
July 09, 2026
Market insights predict the global biologics CDMO industry will increase from USD 29.34 billion in 2026 to USD 107.17 billion by 2035, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is expected to grow fastest. Mammalian types dominated, while microbial types are set to expand. Monoclon...
July 09, 2026
According to market projections, the recombinant proteins sector is expected to grow from USD 3.70 billion in 2026 to USD 8.91 billion by 2035, reflecting a CAGR of 10.24%. In 2024, North America led the global recombinant proteins market with a 42% share. The cytokines & growth factors segment dominated by product, while antibodies are set for...
July 09, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 83.58 billion in 2026 to USD 155.48 billion by 2035, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
July 09, 2026
According to forecasts, the global maternal mental health market will grow from USD 17.02 billion in 2026 to USD 162.27 billion by 2035, with an expected CAGR of 28.47%. In 2024, North America led the maternal mental health market, while Asia Pacific is set for strong growth. Pregnancy and postpartum anxiety dominated by disease indication, with po...
July 09, 2026
According to market projections, the global nitrile gloves market, valued at USD 5.54 billion in 2025, is anticipated to reach USD 13.9 billion by 2035, growing at a CAGR of 9.64% over the next decade. In 2024, North America led the nitrile gloves market with a 36% share, while Asia-Pacific is set for the fastest growth....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
